Why Comprehensive Testing Matters - Ken Schlosser’s Lung Cancer Story

Labcorp, Rebecca Previs, Ken Schlosser, biomarker, lung cancer, ALK+, advocacy, precision

Biomarker testing helped Ken Schlosser live with stage IV lung cancer for over 6 years. Here's how it shaped his care plan from the start.

Jul 31^st • 23 mins listen

Empowering Breast Cancer Patients: Biomarker Breakthroughs & Self-Advocacy

Rebecca Previs, Suzanne Garner, breast cancer, digital, biomarker, genetic testing, advocacy

Suzanne Garner’s journey shows how education, advocacy, and technology are reshaping breast cancer patient care and clinical trial access.

Oct 19^th • 26 mins listen

The Role of MSLs in Achieving Health Equity

health equity, healthcare inequity, pharmaceutical companies, patient advocacy, FDA regulations

In this episode, Ariel Katz, co-founder of H1, joins Tom Caravela to discuss the crucial topic of health equity. Ariel shares insights into his background and the mission of H1, defining health equity and exploring the causes of healthcare inequity. The conversation delves into the roles of MSL…

Jul 12^th • 29 mins listen

Humanizing Cancer Treatment Through Whole-Person Care

City of Hope, Monty Pal, Betty Ferrell, palliative care, quality of life, pain management, bone marrow transplantation, Ethiopia

Dr. Betty Ferrell on her global legacy in palliative care and why whole-person treatment is as crucial as fighting cancer itself.

Apr 21^st • 47 mins listen

Increasing Clinical Trial Access for Blood Cancers

Clinical trials are the best instrument to advance treatment for blood cancers, but numerous challenges exist around trial identification, enrollment, and participation. We’ll hear perspectives from a community provider and patient advocacy organization on immediate—and forward-thinkin…

Jun 7^th • 19 mins listen